shutterstock_559764574_kitreel
Kitreel / Shutterstock.com
18 July 2023FeaturesGenericsCarina Federico and Anne Li

Can pharma firms deduct fees in Hatch-Waxman suits?

For taxpayers, the ability to deduct the entirety of an expense in the current year can be extremely important to their business. The Internal Revenue Service (IRS) and Department of Justice Tax Division continue to assert that, for patent infringement legal fees to be deductible, the issue must be capitalised—rather than deducted.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
2 April 2024   Teva and co-appellant Mylan gain second chance at launching generics of Invega Sustenna, owned by J&J subsidiary Janssen | US Court of Appeals vacates a lower court’s decision to grant validity to the drug’s last remaining patent.
Generics
28 March 2024   Judge disagrees that barrier against generic drug makers should be longer | Pharma company argues that ‘window should be shut’ on copycat versions due to potential for irreparable harm.
Generics
18 February 2024   While President Biden’s desire to reduce costs at the pharmacy counter is commendable, it is too blunt an instrument that would threaten innovation beyond the life sciences, argue former USPTO directors Andrei Iancu and David Kappos.